Earnings History Data for Gossamer Bio (GOSS) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Gossamer Bio
Gossamer Bio Inc. is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing and commercializing therapeutics in the areas of immunology, inflammation and oncology. The company's product pipeline includes GB001, GB002, GB004, GB1275, Autoimmune program and Oncology program which are in clinical stage. Gossamer Bio Inc. is based in San Diego, California.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07-11-2024 | PM | GOSS | Gossamer Bio | 199.00 | -0.14 | -0.18 | 0.00 | Gossamer Bio GAAP EPS of -$0.14, revenue of $9.48M [11/8/2024 12:17 AM] |
0.8780 | -0.01 (-1.01%) |
0.90 | 0.01 (1.45%) |
0.49 - 1.60 | 959,580 | 630,000 | 3,867 | ||
| 12-08-2024 | AH | GOSS | Gossamer Bio | 185.00 | 0.22 | 0.23 | 0.00 | Gossamer Bio GAAP EPS of $0.22, revenue of $88.8M [8/12/2024 5:02 PM] |
0.8323 | 0.04 (4.69%) |
0.83 | 0.04 (4.40%) |
0.45 - 1.60 | 623,210 | 1,200,000 | 24,680 | ||
| 07-05-2024 | AH | GOSS | Gossamer Bio | 167.00 | -0.19 | -0.19 | 0.00 | Gossamer Bio GAAP EPS of -$0.19 in-line [5/7/2024 5:48 PM] |
0.7568 | 0.03 (3.46%) |
0.75 | 0.02 (3.10%) |
0.45 - 1.88 | 4,185,361 | 2,490,000 | 3,837 | ||
| 05-03-2024 | PM | GOSS | Gossamer Bio | 311.00 | -0.21 | -0.20 | 0.00 | Gossamer Bio GAAP EPS of -$0.21 in-line [3/5/2024 7:38 AM] |
1.45 | 0.0 (0.00%) |
1.41 | -0.04 (-2.76%) |
0.45 - 1.88 | 1,091,537 | 1,760,000 | 2,584 | ||
| 17-03-2023 | PM | GOSS | Gossamer Bio, Inc. | 167.22 | -0.59 | -0.62 | -0.74 | Gossamer Bio GAAP EPS of -$0.59 beats by $0.03 [3/17/2023 7:34 AM] |
0.97 | -0.08 (-7.62%) |
1.03 | -0.02 (-1.90%) |
0.96 - 15.19 | 10,927,026 | 4,130,000 | 16,212 | ||
| 03-11-2022 | AH | After the close (Nov 3) |
GOSS | Gossamer Bio | 1,019 | -0.65 | -0.66 | 0.00 | Gossamer Bio GAAP EPS of -$0.65 misses by $0.01 [11/3/2022 5:12 PM] |
10.47 | -0.12 (-1.18%) |
10.60 | 0.0 (0.00%) |
5.64 - 15.20 | 818,359 | 1,390,000 | 9,724 | |
| 09-08-2022 | PM | Before the open (Aug 9) |
GOSS | Gossamer Bio, Inc. | 913.06 | -0.74 | -0.67 | -0.80 | Gossamer Bio GAAP EPS of -$0.74 misses by $0.04 [8/9/2022 8:30 AM] |
12.91 | -0.10 (-0.81%) |
12.62 | -0.40 (-3.07%) |
5.64 - 14.30 | 994,166 | 1,090,000 | 29,026 | |
| 10-05-2022 | AH | 4:00 PM ET (May 10) |
GOSS | Gossamer Bio | 532.00 | -0.76 | -0.77 | 0.00 | Gossamer Bio GAAP EPS of -$0.76 in-line [5/10/2022 5:42 PM] |
7.21 | 0.05 (0.70%) |
7.16 | 0.0 (0.00%) |
6.28 - 14.30 | 779,582 | 1,160,000 | 194,392 | |
| 03-03-2022 | AH | 4:00 PM ET (Mar 3) |
GOSS | Gossamer Bio, Inc. | 690.47 | -0.74 | -0.74 | -0.88 | Gossamer Bio GAAP EPS of -$0.74 misses by $0.02 [3/3/2022 5:34 PM] |
9.65 | 0.61 (6.75%) |
9.04 | 0.0 (0.00%) |
7.04 - 14.30 | 381,910 | 660,000 | 29,432 | |
| 08-11-2021 | AH | 4:00 PM ET (Nov 8) |
GOSS | Gossamer Bio, Inc. | 1,010 | -0.80 | -0.78 | -0.80 | Gossamer Bio EPS misses by $0.02 [11/8/2021 4:15 PM] |
13.10 | -0.25 (-1.87%) |
13.15 | -0.20 (-1.50%) |
7.04 - 14.30 | 637,101 | 590,000 | 773 | |
| 09-08-2021 | AH | 7:30 AM ET (Aug 9) |
GOSS | Gossamer Bio, Inc. | 629.29 | -0.80 | -0.77 | 1.00 | Gossamer Bio EPS misses by $0.04 [8/9/2021 4:35 PM] |
8.18 | -0.18 (-2.15%) |
7.93 | -0.43 (-5.14%) |
7.04 - 15.08 | 921,799 | 400,000 | 22,041 | |
| 06-05-2021 | PM | GOSS | Gossamer Bio, Inc. | 641.00 | -0.78 | -0.80 | 0.00 | Gossamer Bio EPS misses by $0.01 [5/6/2021 8:02 AM] |
8.35 | -0.02 (-0.24%) |
8.35 | 0.0 (0.00%) |
7.92 - 16.79 | 332,504 | 380,000 | 1,402 | ||
| 25-02-2021 | PM | 7:00 AM ET (Feb 25) |
GOSS | Gossamer Bio, Inc. | 766.11 | -0.88 | -0.80 | -0.89 | Gossamer Bio EPS misses by $0.09 [2/25/2021 7:35 AM] |
9.82 | -0.55 (-5.30%) |
10.23 | -0.14 (-1.35%) |
7.52 - 16.79 | 677,539 | 682,820 | 8,979 | |
| 10-11-2020 | AH | 4:00 PM ET (Nov 10) |
GOSS | Gossamer Bio, Inc. | 643.58 | -0.80 | -0.86 | -0.80 | Gossamer Bio EPS beats by $0.04 [11/10/2020 4:29 PM] |
9.17 | -0.09 (-0.97%) |
9.10 | -0.16 (-1.73%) |
7.52 - 27.15 | 532,433 | 609,594 | 21,837 | |
|
|
||||||||||||||||||
| 12-05-2020 | AH | 4:05 PM ET (May 12) |
GOSS | Gossamer Bio, Inc. | 989.91 | -0.87 | -0.80 | -0.90 | Gossamer Bio EPS misses by $0.12 [5/12/2020 4:03 PM] |
13.48 | -2.40 (-15.14%) |
13.49 | 0.01 (0.07%) |
7.52 - 27.15 | 598,799 | 405,282 | 1,496 | |
|
|
||||||||||||||||||